Skip to main content

Khan Najat

CEO And President | Chief R&D Commercial Officer

1 company

Insider Signal Score

49
Average
Trades Analyzed
3
12M Win Rate
-
Avg 3M Return
+16.4%
Avg 12M Return
-

Khan Najat is a CEO And President at Recursion Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.

Estimated insider holdings value: $7.2M based on current market prices.

Holdings by Company

RXRXMar 9, 2026
Current Shares2.26M
Value$7.19M
Net Activity-189,300
Bought: 0Sold: 189.3K

Transaction History

Showing 3 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Mar 9, 2026
RXRX
Recursion Pharmaceuticals, Inc.
CEO And PresidentSell28,298$3.35$94,659.64-1.2%+2.8%-
Dec 22, 2025
RXRX
Recursion Pharmaceuticals, Inc.
Chief R&D Commercial OfficerSell124,403$4.41$548,592.35-16.9%-26.6%-
Aug 18, 2025
RXRX
Recursion Pharmaceuticals, Inc.
Chief R&D Commercial OfficerSell36,599$5.52$202,172.88-5.2%-25.4%-